These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33434738)

  • 21. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    de Vos C; Leopold K; Blanke ES; Siebert S; Baumgardt J; Burkhardt E; Bechdolf A
    Psychiatry Res; 2020 Nov; 293():113424. PubMed ID: 32862065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adversity in childhood/adolescence and premorbid tobacco, alcohol, and cannabis use among first-episode psychosis patients.
    Langlois S; Zern A; Kelley ME; Compton MT
    Early Interv Psychiatry; 2021 Oct; 15(5):1335-1342. PubMed ID: 33289325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.
    Compton MT; Broussard B; Ramsay CE; Stewart T
    Schizophr Res; 2011 Mar; 126(1-3):71-6. PubMed ID: 21036542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M; van der Sluis S; de Haan L
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis.
    van der Meer FJ; Velthorst E; Meijer CJ; Machielsen MW; de Haan L
    Curr Pharm Des; 2012; 18(32):5036-44. PubMed ID: 22716158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol and cannabis use in Urban, African American, first-episode schizophrenia-spectrum patients: associations with positive and negative symptoms.
    Compton MT; Whicker NE; Hochman KM
    J Clin Psychiatry; 2007 Dec; 68(12):1939-45. PubMed ID: 18162026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive course in first-episode psychosis and clinical correlates: A 4 year longitudinal study using the MATRICS Consensus Cognitive Battery.
    Kenney J; Anderson-Schmidt H; Scanlon C; Arndt S; Scherz E; McInerney S; McFarland J; Byrne F; Ahmed M; Donohoe G; Hallahan B; McDonald C; Cannon DM
    Schizophr Res; 2015 Dec; 169(1-3):101-108. PubMed ID: 26416442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
    Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
    Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.
    Kelleher I; Clarke MC; Rawdon C; Murphy J; Cannon M
    Schizophr Bull; 2013 Sep; 39(5):1018-26. PubMed ID: 22927672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis.
    Grossman M; Bowie CR; Lepage M; Malla AK; Joober R; Iyer SN
    J Psychiatr Res; 2017 Feb; 85():83-90. PubMed ID: 27863280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers.
    de la Serna E; Mayoral M; Baeza I; Arango C; Andrés P; Bombin I; González C; Rapado M; Robles O; Rodríguez-Sánchez JM; Zabala A; Castro-Fornieles J
    J Nerv Ment Dis; 2010 Feb; 198(2):159-62. PubMed ID: 20145493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairments in patients with first episode psychosis: The relationship between neurophysiological and neuropsychological assessments.
    Morales-Muñoz I; Jurado-Barba R; Fernández-Guinea S; Álvarez-Alonso MJ; Rodríguez-Jiménez R; Jiménez-Arriero MA; Rubio G
    J Clin Neurosci; 2017 Feb; 36():80-87. PubMed ID: 27825609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors.
    Ayesa-Arriola R; Alcaraz EG; Hernández BV; Pérez-Iglesias R; López Moríñigo JD; Duta R; David AS; Tabares-Seisdedos R; Crespo-Facorro B
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2278-88. PubMed ID: 26475577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
    Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of cannabis exposure relative to prodrome and psychosis onset in a community-based first episode psychosis sample.
    Kline ER; Ferrara M; Li F; D'Souza DC; Keshavan M; Srihari VH
    J Psychiatr Res; 2022 Mar; 147():248-253. PubMed ID: 35066293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.